New drug combo shows promise for Hard-to-Treat ovarian cancer
Disease control
Not yet recruiting
This study tests two new drug combinations given before surgery for people with advanced ovarian cancer that cannot be fully removed right away. The goal is to shrink the tumor enough to allow successful surgery. About 104 participants with a specific type of ovarian cancer (BRCA…
Phase: PHASE2 • Sponsor: Qinglei Gao • Aim: Disease control
Last updated May 14, 2026 12:02 UTC